Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
COST PLUS INC (CPWM)
|
Add to portfolio |
|
|
|
| Price: |
$7.86
| | Metrics |
| OS: |
22.5
|
M
| |
9
|
% ROE
|
| Market cap: |
$177
|
M
| |
20
|
% ROIC
|
|
Net debt:
|
$24.6
|
M
| |
0.3
|
x Debt/EBITDA
|
|
EV:
|
$202
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$72.6
|
M
| |
2.8
|
x EV/EBITDA
|
|
EBIT
|
$54.0
|
M
| |
3.7
|
x EV/EBIT
|
| EPS |
$0.86
| |
9.1
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jan-28-12 | Jan-29-11 | Jan-30-10 | Jan-31-09 | Jan-03-09 | Feb-02-08 | Feb-03-07 | Jan-28-06 |
| Revenues | 963.8 | 916.6 | 867.0 | 948.7 | | 949.8 | 1,010.1 | 970.4 |
| Revenue growth | 5.2% | 5.7% | -8.6% | -0.1% | | -6.0% | 4.1% | 6.8% |
| Cost of goods sold | 654.2 | 625.6 | 637.9 | 702.2 | | 679.0 | 715.5 | 649.0 |
| Gross profit | 309.6 | 290.9 | 229.2 | 246.4 | | 270.9 | 294.7 | 321.4 |
| Gross margin | 32.1% | 31.7% | 26.4% | 26.0% | | 28.5% | 29.2% | 33.1% |
| Selling, general and administrative | 277.4 | 270.9 | 270.9 | 313.7 | | 303.2 | 308.7 | 281.7 |
| EBIT | 32.0 | 19.8 | -41.9 | -95.9 | | -58.8 | -34.0 | 31.5 |
| EBIT margin | 3.3% | 2.2% | -4.8% | -10.1% | | -6.2% | -3.4% | 3.2% |
| Pre-tax income | 19.3 | 5.6 | -58.9 | -83.1 | | -47.2 | -31.0 | 26.4 |
| Income taxes | 1.6 | 0.9 | -12.7 | 0.8 | | 0.0 | -10.7 | 9.8 |
| Tax rate | 8.1% | 15.8% | 21.6% | | | | 34.5% | 37.0% |
| Earnings from continuing ops | 17.7 | 4.7 | -46.2 | -83.8 | | -47.2 | -20.3 | 16.6 |
| Earnings from discontinued ops | | | | | | | -2.2 | |
| Net income | 16.5 | 2.9 | -63.3 | -102.7 | | -55.5 | -22.5 | 16.6 |
| Net margin | 1.7% | 0.3% | -7.3% | -10.8% | | -5.8% | -2.2% | 1.7% |
| |
| Diluted EPS | $0.76 | $0.21 | ($2.09) | ($3,794.72) | | ($2.14) | ($0.92) | $0.75 |
| Shares outstanding (diluted) | 23.4 | 22.6 | 22.1 | 0.0 | | 22.1 | 22.1 | 22.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|